US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

2.000 +0.070 (+3.63%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Price 2.000
Open 1.960
Prev. Close 1.930
Change
+0.07
% Change
+3.63%
Bid (Size) 1.930 (100)
Ask (Size) 2.200 (2,000)
High 2.016
Low 1.932
52 Week High 2.610
52 Week Low 1.330
EPS 0.4800
Price / Earnings 4.167
Dividend Yield N/A
Shares Outstanding 31,056,238
Volume 434,457
Average Volume (3 Mo) 677K

Chart

Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Price Performance

YTD
+0.05 (2.56%)
1 Month
-0.50 (-20.00%)
3 Month
+0.02 (1.01%)
6 Month
+0.21 (11.73%)
1 Year
+0.36 (21.95%)